Paraoxonase/arylesterase in serum of patients with type II diabetes mellitus
- PMID: 16613735
Paraoxonase/arylesterase in serum of patients with type II diabetes mellitus
Abstract
The aim of this study was to determine whether the paraoxonase (PON1) status, i.e. PON1 activities and phenotypes (AA, AB and BB), and its relationship with lipid status are different in patients with type II diabetes as compared to healthy population. Diabetic group comprised 175 patients with type II diabetes mellitus (94 men and 81 women) who came to their regular control examination and took the oral glucose tolerance test. Patients with type II diabetes mellitus diagnosis for 12 years on average were on peroral antidiabetics, or insulin or diet, and 3 patients had no therapy prescribed yet. Control group comprised 114 apparently healthy individuals (28 men and 86 women) who were not on any medication. The paraoxonase activity was measured with 2.0 mmol L(-1) paraoxon in the absence and in the presence of 1.0 mol L(-1) NaCl, and with 2.0 mmol L(-1) phenylacetate. Both activities were measured spectrophotometrically at 37 degrees C in 0.1 mol L(-1) Tris-HCl buffer, pH = 8.0, containing 2.0 mmol L(-1) CaCl(2). Sera of diabetic and control subjects were assigned to the paraoxonase phenotypes on the basis of the basal paraoxonase activity distribution. We assigned 45% sera of male and 49% sera of female diabetic patients, and 64% sera of both genders of the control group to the AA low activity phenotype. There were no differences in paraoxonase activities between the gender- and phenotype-matched diabetic and control groups. Enzyme activity against the phenylacetate was higher, and phenotype-dependent, only in diabetic patients. In contrast to AA phenotype individuals, total cholesterol and LDL-cholesterol in the female diabetic group and triglyceride concentration in the male diabetic group assigned to pooled AB and BB phenotypes were higher than in the corresponding controls. It follows from PON1 phenotype distribution that less antiatherogenic paraoxonase B allele is more frequent in type II diabetes mellitus than in the healthy population. Their lipid status is more atherogenic, which could indicate a risk of premature atherosclerosis.
Similar articles
-
Modulating effect of atorvastatin on paraoxonase 1 activity in type 2 diabetic Egyptian patients with or without nephropathy.J Diabetes Complications. 2010 Sep-Oct;24(5):325-33. doi: 10.1016/j.jdiacomp.2009.04.001. Epub 2009 Jun 23. J Diabetes Complications. 2010. PMID: 19553142 Clinical Trial.
-
Relations of lysophosphatidylcholine in low-density lipoprotein with serum lipoprotein-associated phospholipase A2, paraoxonase and homocysteine thiolactonase activities in patients with type 2 diabetes mellitus.Diabetes Res Clin Pract. 2009 Nov;86(2):117-23. doi: 10.1016/j.diabres.2009.08.014. Epub 2009 Sep 11. Diabetes Res Clin Pract. 2009. PMID: 19748147
-
Assessment of paraoxonase activity and lipid peroxidation levels in diabetic and senile subjects suffering from cataract.Clin Biochem. 2007 Jun;40(9-10):705-9. doi: 10.1016/j.clinbiochem.2007.03.015. Epub 2007 Mar 28. Clin Biochem. 2007. PMID: 17466963
-
[Caries status in diabetic patients].Fogorv Sz. 1991 Sep;84(9):267-74. Fogorv Sz. 1991. PMID: 1936354 Review. Hungarian.
-
Catalytic properties and distribution profiles of paraoxonase and cholinesterase phenotypes in human sera.Toxicol Lett. 1995 Dec;82-83:447-52. doi: 10.1016/0378-4274(95)03494-3. Toxicol Lett. 1995. PMID: 8597092 Review.
Cited by
-
Oxytocin induced oxidative stress in lactating Bubalis bubalis (Nili Ravi).BMC Vet Res. 2013 Aug 27;9:169. doi: 10.1186/1746-6148-9-169. BMC Vet Res. 2013. PMID: 23981231 Free PMC article.
-
Evaluation of Relationship Between Arylesterase-Based Activity and Genetic Variants of Paraoxonase1 in T2DM Patients within Golestan Province.Indian J Clin Biochem. 2020 Apr;35(2):239-244. doi: 10.1007/s12291-019-00822-3. Epub 2019 Mar 5. Indian J Clin Biochem. 2020. PMID: 32226257 Free PMC article.
-
Strychnos nux-vomica L. seed preparation promotes functional recovery and attenuates oxidative stress in a mouse model of sciatic nerve crush injury.BMC Complement Med Ther. 2020 Jun 11;20(1):181. doi: 10.1186/s12906-020-02950-3. BMC Complement Med Ther. 2020. PMID: 32527244 Free PMC article.
-
Punicalagin Decreases Serum Glucose Levels and Increases PON1 Activity and HDL Anti-Inflammatory Values in Balb/c Mice Fed a High-Fat Diet.Oxid Med Cell Longev. 2018 Jul 31;2018:2673076. doi: 10.1155/2018/2673076. eCollection 2018. Oxid Med Cell Longev. 2018. PMID: 30151068 Free PMC article.
-
Frontocingulate Dysfunction Is Associated with Depression and Decreased Serum PON1 in Methamphetamine-Dependent Patients.Neuropsychiatr Dis Treat. 2020 Feb 19;16:489-499. doi: 10.2147/NDT.S237528. eCollection 2020. Neuropsychiatr Dis Treat. 2020. PMID: 32110023 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical
Miscellaneous